Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Paul Sandor |
Documentos disponibles escritos por este autor (3)
Refinar búsqueda
Aggressive behaviour in children with Tourette syndrome and comorbid attention deficit hyperactivity disorder and obsessive compulsive disorder / Robyn J. Stephens en The Canadian Journal of Psychiatry, Año 1999 Vol. 44 - No.10 (Diciembre)
[artículo]
Título : Aggressive behaviour in children with Tourette syndrome and comorbid attention deficit hyperactivity disorder and obsessive compulsive disorder Tipo de documento: texto impreso Autores: Robyn J. Stephens, Autor ; Paul Sandor, Autor Fecha de publicación: 2022 Artículo en la página: pp. 1036–1042 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agresión - psicología, Trastorno por Déficit de Atención e Hiperactividad, Trastornos del Comportamiento Infantil, Entrevista psicológica, Trastorno obsesivo compulsivo, Índice de gravedad de la enfermedad, Síndrome de Tourette. Resumen: Aggressive behaviour, defined as sudden, explosive outbursts of rage, has been reported as a clinical problem in approximately 23% to 40% of Tourette syndrome (TS) patients (1–5). Attention-deficit hyperactivity disorder (ADHD) and obsessive–compulsive disorder (OCD) are also reported in 50% to 70% of TS patients (6). Link: ./index.php?lvl=notice_display&id=29076
in The Canadian Journal of Psychiatry > Año 1999 Vol. 44 - No.10 (Diciembre) . - pp. 1036–1042[artículo] Aggressive behaviour in children with Tourette syndrome and comorbid attention deficit hyperactivity disorder and obsessive compulsive disorder [texto impreso] / Robyn J. Stephens, Autor ; Paul Sandor, Autor . - 2022 . - pp. 1036–1042.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Canadian Journal of Psychiatry > Año 1999 Vol. 44 - No.10 (Diciembre) . - pp. 1036–1042
Palabras clave: Agresión - psicología, Trastorno por Déficit de Atención e Hiperactividad, Trastornos del Comportamiento Infantil, Entrevista psicológica, Trastorno obsesivo compulsivo, Índice de gravedad de la enfermedad, Síndrome de Tourette. Resumen: Aggressive behaviour, defined as sudden, explosive outbursts of rage, has been reported as a clinical problem in approximately 23% to 40% of Tourette syndrome (TS) patients (1–5). Attention-deficit hyperactivity disorder (ADHD) and obsessive–compulsive disorder (OCD) are also reported in 50% to 70% of TS patients (6). Link: ./index.php?lvl=notice_display&id=29076 Current status of genetic studies of Gilles de la Tourette syndrome / Cathy L. Barr en The Canadian Journal of Psychiatry, Año 1998 Vol. 43 - No. 4 (Mayo)
[artículo]
Título : Current status of genetic studies of Gilles de la Tourette syndrome Tipo de documento: texto impreso Autores: Cathy L. Barr, Autor ; Paul Sandor, Autor Fecha de publicación: 2022 Artículo en la página: pp. 351–357 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Adopción, Enfermedades en Gemelos, Trastorno obsesivo-compulsivo, Síndrome de Tourette. Resumen: Gilles de la Tourette syndrome (TS) is a familial, neuropsychiatric disorder characterized by chronic, intermittent motor and vocal tics. Despite strong evidence for a genetic basis of this disorder from family, twin, and adoption studies, no convincing evidence for genetic linkage has been reported. Link: ./index.php?lvl=notice_display&id=29202
in The Canadian Journal of Psychiatry > Año 1998 Vol. 43 - No. 4 (Mayo) . - pp. 351–357[artículo] Current status of genetic studies of Gilles de la Tourette syndrome [texto impreso] / Cathy L. Barr, Autor ; Paul Sandor, Autor . - 2022 . - pp. 351–357.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Canadian Journal of Psychiatry > Año 1998 Vol. 43 - No. 4 (Mayo) . - pp. 351–357
Palabras clave: Adopción, Enfermedades en Gemelos, Trastorno obsesivo-compulsivo, Síndrome de Tourette. Resumen: Gilles de la Tourette syndrome (TS) is a familial, neuropsychiatric disorder characterized by chronic, intermittent motor and vocal tics. Despite strong evidence for a genetic basis of this disorder from family, twin, and adoption studies, no convincing evidence for genetic linkage has been reported. Link: ./index.php?lvl=notice_display&id=29202 Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial / Yves Dion en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Febrero)
[artículo]
Título : Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial Tipo de documento: texto impreso Autores: Yves Dion, Autor ; Lawrence Annable, Autor ; Paul Sandor, Autor Fecha de publicación: 2023 Artículo en la página: pp. 31-39 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Discinesia inducida por fármacos, Examen neurológico, Risperidona, Síndrome de Tourette. Resumen: A double-blind, placebo-controlled trial was performed to determine the efficacy and tolerability of 8 weeks of treatment with risperidone in the management of 48 adolescent and adult patients with Tourette syndrome. Twenty-four patients were randomly assigned to treatment with risperidone in doses of 0.5 to 6.0 mg/day, and 24 were assigned to placebo. Link: ./index.php?lvl=notice_display&id=31091
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 31-39[artículo] Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial [texto impreso] / Yves Dion, Autor ; Lawrence Annable, Autor ; Paul Sandor, Autor . - 2023 . - pp. 31-39.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 31-39
Palabras clave: Discinesia inducida por fármacos, Examen neurológico, Risperidona, Síndrome de Tourette. Resumen: A double-blind, placebo-controlled trial was performed to determine the efficacy and tolerability of 8 weeks of treatment with risperidone in the management of 48 adolescent and adult patients with Tourette syndrome. Twenty-four patients were randomly assigned to treatment with risperidone in doses of 0.5 to 6.0 mg/day, and 24 were assigned to placebo. Link: ./index.php?lvl=notice_display&id=31091